Analgesic efficacy of buprenorphine in the presence of high levels of SDF-1α/CXCL12 in the brain

Drug and Alcohol Dependence

Volumn 114, Issue 2-3, 2011, Pages 246-248

  Benamar, Khalid ^a   Palma, Jonathan ^a   Cowan, Alan ^a   Geller, Ellen B ^a   Adler, Martin W ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Analgesia. PAG; Buprenorphine; Chemokine

Indexed keywords

BUPRENORPHINE; STROMAL CELL DERIVED FACTOR 1; STROMAL CELL DERIVED FACTOR 1ALPHA;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; MALE; NONHUMAN; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; RAT;

ANALGESICS, OPIOID; ANIMALS; BRAIN CHEMISTRY; BUPRENORPHINE; CHEMOKINE CXCL12; MALE; PAIN MEASUREMENT; RATS; RATS, SPRAGUE-DAWLEY; TREATMENT OUTCOME;

RATTUS;

EID: 79952697438     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2010.08.015     Document Type: Article

References (24)

1. Adler M.W., Geller E.B., Chen X., Rogers T.J. Viewing chemokines as a third major system of communication in the brain. AAPS J. 2006, 7:E865-E870.
2. Adler M.W., Rogers T.J. Are chemokines the third major system in the brain?. J. Leukoc. Biol. 2005, 78:1204-1209.
3. Benamar K., Rawls S.M., Geller E.B., Adler M.W. Intrahypothalamic injection of deltorphin-II alters body temperature in rats. Brain Res 2004, 1019:22-27.
4. Bulka A., Kouya P.F., Bottiger Y., Svensson J.O., Xu X.J., Wiesenfeld-Hallin Z. Comparison of the antinociceptive effect of morphine, methadone, buprenorphine and codeine in two substrains of Sprague-Dawley rats. Eur. J. Pharmacol. 2004, 492:27-34.
5. Dahan A., Yassen A., Bijl H., Romberg R., Sarton E., Teppema L., Olofsen E., Danhof M. Comparison of the respiratory effects of intravenous buprenorphine and fentanyl in humans and rats. Br. J. Anaesth. 2005, 94:825-834.
6. Evans H.C., Easthope S.E. Transdermal buprenorphine. Drugs 2003, 63:1999-2010. discussion 2011-2.
7. Franchi S., Panerai A.E., Sacerdote P. Buprenorphine ameliorates the effect of surgery on hypothalamus-pituitary-adrenal axis, natural killer cell activity and metastatic colonization in rats in comparison with morphine or fentanyl treatment. Brain Behav. Immun. 2007, 21:767-774.
8. Gomez-Flores R., an Weber R.J. Differential effects of buprenorphine and morphine on immune and neuroendocrine functions following acute administration in the rat mesencephalon periaqueductal gray. Immunopharmacology 2000, 48:145-156.
9. Griessinger N., Sittl R., Likar R. Transdermal buprenorphine in clinical practice-a post-marketing surveillance study in 13,179 patients. Curr. Med. Res. Opin. 2005, 21:1147-1156.
10. Guindon J., Walczak J.S., Beaulieu P. Recent advances in the pharmacological management of pain. Drugs 2007, 67:2121-2133.
11. Heel R.C., Brogden R.N., Speight T.M., Avery G.S. Buprenorphine: a review of its pharmacological properties and therapeutic efficacy. Drugs 1979, 17:81-110.
12. Kay B. A double-blind comparison of morphine and buprenorphine in the prevention of pain after operation. Br. J. Anaesth. 1978, 50:605-609.
13. Leander J.D., Gesellchen P.D., Mendelsohn L.G. Opioid antinociceptive effects of delta-receptor antagonists. Pharmacol. Biochem. Behav. 1988, 29:351-355.
14. Lutfy K., Cowan A. Buprenorphine: a unique drug with complex pharmacology. Curr. Neuropharmacol. 2004, 2:395-402.
15. Marquez P., Borse J., Nguyen A.T., Hamid A., Lutfy K. The role of the opioid receptor-like (ORL1) receptor in motor stimulatory and rewarding actions of buprenorphine and morphine. Neuroscience 2008, 155:597-602.
16. Martin W.R., Eades C.G., Thompson J.A., Huppler R.E., Gilbert P.E. The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog. J. Pharmacol. Exp. Ther. 1976, 197:517-532.
17. Martucci C., Panerai A.E., Sacerdote P. Chronic fentanyl or buprenorphine infusion in the mouse: similar analgesic profile but different effects on immune responses. Pain 2004, 110:385-392.
18. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 1998, Academic Press, San Diego.
19. Pizziketti R.J., Pressman N.S., Geller E.B., Cowan A., Adler M.W. Rat cold water tail-flick: a novel analgesic test that distinguishes opioid agonists from mixed agonist-antagonists. Eur. J. Pharmacol. 1985, 119:23-29.
20. Richards M.L., Sadee W. In vivo opiate receptor binding of oripavines to mu, delta and kappa sites in rat brain as determined by an ex vivo labeling method. Eur. J. Pharmacol. 1985, 114:343-353.
21. Robinson S.E. Buprenorphine: an analgesic with an expanding role in the treatment of opioid addiction. CNS Drug Rev. 2002, 8:377-390.
22. Sacerdote P., Franchi S., Gerra G., Leccese V., Panerai A.E., Somaini L. Buprenorphine and methadone maintenance treatment of heroin addicts preserves immune function. Brain Behav. Immun. 2008, 22:606-613.
23. Walsh S.L., Eissenberg T. The clinical pharmacology of buprenorphine: extrapolating from the laboratory to the clinic. Drug Alcohol Depend. 2003, 70:S13-27.
24. Walsh S.L., June H.L., Schuh K.J., Preston K.L., Bigelow G.E., Stitzer M.L. Effects of buprenorphine and methadone in methadone-maintained subjects. Psychopharmacology (Berl.) 1995, 119:268-276.